Retatrutide is a synthetic peptide designed to activate three metabolic hormone receptors—GLP-1, GIP, and glucagon receptors. It has been investigated for its effects on incretin signaling, cAMP pathways, glucose regulation, and energy metabolism.
This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical treatment, diagnostic use, or veterinary applications. Purchasers are responsible for ensuring compliance with all applicable laws and regulations regarding the handling and use of research materials.
Retatrutide is a triple receptor agonist that combines activity at the glucagon-like peptide-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR). Research has examined its receptor-specific molecular interactions, cAMP signaling, glucose and lipid metabolism, energy balance, and the biological effects resulting from simultaneous activation of these three pathways.
For a research-use-only catalog, Retatrutide is suitable for research involving:
Purity: ≥98%